145 related articles for article (PubMed ID: 34611846)
21. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31.
Chen N; Kroger CJ; Tisch RM; Bachelder EM; Ainslie KM
Adv Healthc Mater; 2018 Sep; 7(18):e1800341. PubMed ID: 30051618
[TBL] [Abstract][Full Text] [Related]
23. Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction.
Rhodes KR; Meyer RA; Wang J; Tzeng SY; Green JJ
Acta Biomater; 2020 Aug; 112():136-148. PubMed ID: 32522714
[TBL] [Abstract][Full Text] [Related]
24. A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells.
Chen LC; Nicholson YT; Rosborough BR; Thomson AW; Raimondi G
J Immunol; 2016 Aug; 197(4):1137-47. PubMed ID: 27402696
[TBL] [Abstract][Full Text] [Related]
25. Biomaterials-based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents.
Marshall GP; Cserny J; Wang CW; Looney B; Posgai AL; Bacher R; Keselowsky B; Brusko TM
J Biomed Mater Res A; 2023 Feb; 111(2):185-197. PubMed ID: 36082558
[TBL] [Abstract][Full Text] [Related]
26. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
[TBL] [Abstract][Full Text] [Related]
27. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
Turner MS; Kane LP; Morel PA
J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants.
Li Y; Frei AW; Labrada IM; Rong Y; Liang JP; Samojlik MM; Sun C; Barash S; Keselowsky BG; Bayer AL; Stabler CL
Front Immunol; 2021; 12():653088. PubMed ID: 34122410
[TBL] [Abstract][Full Text] [Related]
29. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
30. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
31. Direct modulation of myelin-autoreactive CD4
Pei W; Wan X; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
Int J Nanomedicine; 2018; 13():3731-3750. PubMed ID: 29983566
[TBL] [Abstract][Full Text] [Related]
32. Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells.
Gammon JM; Gosselin EA; Tostanoski LH; Chiu YC; Zeng X; Zeng Q; Jewell CM
J Control Release; 2017 Oct; 263():151-161. PubMed ID: 28257991
[TBL] [Abstract][Full Text] [Related]
33. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes.
Sharp RC; Brown ME; Shapiro MR; Posgai AL; Brusko TM
Front Immunol; 2021; 12():739048. PubMed ID: 34603322
[TBL] [Abstract][Full Text] [Related]
34. Migratory properties of ex vivo expanded regulatory T cells: Influence of all-trans retinoic acid and rapamycin.
Beermann JL; Thiesler CT; Dringenberg U; Alter C; Kuhs S; Velaga S; Ukena SN; Franzke A
Transpl Immunol; 2017 Dec; 45():29-34. PubMed ID: 28870639
[TBL] [Abstract][Full Text] [Related]
35. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
36. All-trans Retinoic Acid Regulates the Balance of Treg-Th17 Cells through ERK and P38 Signaling Pathway.
Wu S; Wang W; Le Q
Iran J Immunol; 2019 Mar; 16(1):1-10. PubMed ID: 30864551
[TBL] [Abstract][Full Text] [Related]
37. What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N; Schwab C; Grimbacher B
Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
[TBL] [Abstract][Full Text] [Related]
38. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
Kornete M; Piccirillo CA
Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
[TBL] [Abstract][Full Text] [Related]
39. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.
Schmidt EM; Wang CJ; Ryan GA; Clough LE; Qureshi OS; Goodall M; Abbas AK; Sharpe AH; Sansom DM; Walker LS
J Immunol; 2009 Jan; 182(1):274-82. PubMed ID: 19109158
[TBL] [Abstract][Full Text] [Related]
40. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.
Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA
Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
